Mycobacteria Therapeutics Receives $150K in State Funding

Written By Adam Bohr

We are excited to announce our successful grant proposal to the Colorado Office of Economic Development and International Trade. The Advanced Industry Accelerator proof of concept grant will fund research by CSO Chris Lowry, PhD and CTO Noah Fierer, PhD to isolate 10 novel strains of Mycobacteria for development. Read the full press release here.

Adam Bohr
Previous

Eatingwell.com Article Features Company Founders
Next

Mycobacteria Therapeutics Takes Third at University of Colorado Boulder Start-Up Competition